Cutera, Inc. (NASDAQ:CUTR) EVP Larry Laber sold 500 shares of the stock in a transaction on Monday, November 6th. The stock was sold at an average price of $41.50, for a total value of $20,750.00. Following the completion of the transaction, the executive vice president now owns 72,413 shares of the company’s stock, valued at approximately $3,005,139.50. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link.

Larry Laber also recently made the following trade(s):

  • On Wednesday, November 8th, Larry Laber sold 1,700 shares of Cutera stock. The stock was sold at an average price of $42.15, for a total value of $71,655.00.
  • On Monday, October 16th, Larry Laber sold 500 shares of Cutera stock. The stock was sold at an average price of $40.50, for a total value of $20,250.00.

Shares of Cutera, Inc. (NASDAQ CUTR) traded up $0.85 on Friday, hitting $42.45. The stock had a trading volume of 317,300 shares, compared to its average volume of 134,765. The firm has a market cap of $576.37, a price-to-earnings ratio of 53.33, a price-to-earnings-growth ratio of 1.73 and a beta of 0.49. Cutera, Inc. has a one year low of $13.70 and a one year high of $44.40.

Cutera (NASDAQ:CUTR) last issued its earnings results on Tuesday, November 7th. The medical device company reported $0.42 EPS for the quarter, topping the consensus estimate of $0.08 by $0.34. Cutera had a return on equity of 18.73% and a net margin of 7.99%. The company had revenue of $38.17 million during the quarter, compared to analyst estimates of $34.82 million. During the same quarter last year, the firm earned $0.12 EPS. The business’s revenue was up 26.1% on a year-over-year basis. research analysts anticipate that Cutera, Inc. will post 0.55 earnings per share for the current fiscal year.

Cutera declared that its board has initiated a share buyback plan on Monday, August 7th that authorizes the company to buyback $25.00 million in shares. This buyback authorization authorizes the medical device company to reacquire up to 6.8% of its stock through open market purchases. Stock buyback plans are often a sign that the company’s board of directors believes its stock is undervalued.

COPYRIGHT VIOLATION NOTICE: “Cutera, Inc. (CUTR) EVP Sells $20,750.00 in Stock” was reported by Watch List News and is the property of of Watch List News. If you are reading this story on another site, it was illegally copied and reposted in violation of US and international copyright & trademark laws. The correct version of this story can be accessed at https://www.watchlistnews.com/cutera-inc-cutr-evp-sells-20750-00-in-stock/1696084.html.

CUTR has been the subject of several research analyst reports. Roth Capital increased their price objective on Cutera from $41.00 to $47.00 and gave the stock a “buy” rating in a research report on Tuesday, September 12th. BidaskClub lowered Cutera from a “strong-buy” rating to a “buy” rating in a report on Wednesday, July 19th. Gabelli reissued a “buy” rating on shares of Cutera in a report on Wednesday, August 9th. TheStreet raised Cutera from a “c” rating to a “b” rating in a research note on Friday, August 18th. Finally, Maxim Group downgraded Cutera from a “buy” rating to a “hold” rating in a report on Thursday, September 14th. Two analysts have rated the stock with a hold rating and four have issued a buy rating to the company’s stock. Cutera presently has an average rating of “Buy” and an average target price of $37.33.

A number of large investors have recently added to or reduced their stakes in the stock. Renaissance Technologies LLC boosted its position in Cutera by 0.8% during the 2nd quarter. Renaissance Technologies LLC now owns 1,214,500 shares of the medical device company’s stock valued at $31,456,000 after purchasing an additional 9,100 shares during the period. Gamco Investors INC. ET AL boosted its position in Cutera by 3.7% during the 2nd quarter. Gamco Investors INC. ET AL now owns 576,363 shares of the medical device company’s stock valued at $14,928,000 after purchasing an additional 20,363 shares during the period. Vanguard Group Inc. boosted its position in Cutera by 3.4% during the 2nd quarter. Vanguard Group Inc. now owns 570,948 shares of the medical device company’s stock valued at $14,788,000 after purchasing an additional 18,549 shares during the period. Kennedy Capital Management Inc. acquired a new position in Cutera during the 2nd quarter valued at approximately $9,426,000. Finally, Teton Advisors Inc. boosted its position in Cutera by 6.7% during the 2nd quarter. Teton Advisors Inc. now owns 319,000 shares of the medical device company’s stock valued at $8,262,000 after purchasing an additional 20,000 shares during the period. Institutional investors and hedge funds own 88.72% of the company’s stock.

Cutera Company Profile

Cutera, Inc is a medical device company. The Company is engaged in the design, development, manufacture, marketing and servicing of laser and other energy-based aesthetics systems for practitioners across the world. The Company offers products based on product platforms, such as enlighten, excel HR, truSculpt, excel V and xeo, each of which enables physicians and other practitioners to perform aesthetic procedures for customers.

Insider Buying and Selling by Quarter for Cutera (NASDAQ:CUTR)

Receive News & Ratings for Cutera Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cutera Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.